Cargando…

Hypermethylation of brain natriuretic peptide gene is associated with the risk of rheumatic heart disease

To investigate the contribution of brain natriuretic peptide (BNP) promoter DNA methylation to the risk of rheumatic heart disease (RHD) and the influence of warfarin anticoagulant therapy on BNP methylation levels for RHD patients after surgery. BNP methylation levels were determined by bisulfite p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ni, Zheng, Dawei, Sun, Lebo, Shi, Huoshun, Zhu, Xiuying, Xu, Guodong, Wang, Qinning, Zhu, Caimin, Shao, Guofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240589/ https://www.ncbi.nlm.nih.gov/pubmed/27920275 http://dx.doi.org/10.1042/BSR20160408

Ejemplares similares

Efficient detection of differentially methylated regions in the genome of patients with thoracic aortic dissection and association with MMP2 hypermethylation
por: Li, Ni, et al.
Publicado: (2020)

Differentially methylated regions in patients with rheumatic heart disease and secondary pulmonary arterial hypertension
por: Zheng, Dawei, et al.
Publicado: (2017)

BMPR2 promoter methylation and its expression in valvular heart disease complicated with pulmonary artery hypertension
por: Li, Ni, et al.
Publicado: (2021)

Long Noncoding RNA HLA Complex Group 18 Improves the Cell Proliferation of Myocardial Fibroblasts by Regulating the Hsa-microRNA-133a/Epidermal Growth Factor Receptor Axis
por: Shi, Huoshun, et al.
Publicado: (2022)

miRNA-1183-targeted regulation of Bcl-2 contributes to the pathogenesis of rheumatic heart disease
por: Li, Ni, et al.
Publicado: (2020)

Detection of Differentially Expressed MicroRNAs in Rheumatic Heart Disease: miR-1183 and miR-1299 as Potential Diagnostic Biomarkers
por: Li, Ni, et al.
Publicado: (2015)

MicroRNA-9 Enhanced Cisplatin Sensitivity in Nonsmall Cell Lung Cancer Cells by Regulating Eukaryotic Translation Initiation Factor 5A2
por: Pan, Qiaoling, et al.
Publicado: (2018)

Hsa_circ_0000437 upregulates and promotes disease progression in rheumatic valvular heart disease
por: Zhu, Linwen, et al.
Publicado: (2021)

Cisplatin sensitivity is enhanced in non-small cell lung cancer cells by regulating epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2
por: Xu, Guodong, et al.
Publicado: (2014)

Comparison of the Ventricle Muscle Proteome between Patients with Rheumatic Heart Disease and Controls with Mitral Valve Prolapse: HSP 60 May Be a Specific Protein in RHD
por: Zheng, Dawei, et al.
Publicado: (2014)

Amino-terminal pro-brain natriuretic peptide in children with latent rheumatic heart disease
por: Zachariah, Justin P, et al.
Publicado: (2016)

Effects of glutamine and valsartan on the brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide of patients with chronic heart failure
por: Shao, Mingliang, et al.
Publicado: (2015)

Heads and Tails of Natriuretic Peptides: Neuroprotective Role of Brain Natriuretic Peptide
por: Fernández‐Susavila, Héctor, et al.
Publicado: (2017)

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department
por: Nayer, Jamshed, et al.
Publicado: (2014)

Natriuretic Peptides in Chronic Heart Failure
por: Brunner-La Rocca, Hans-Peter, et al.
Publicado: (2019)

The effects of novel coronavirus (SARS-CoV-2) infection on cardiovascular diseases and cardiopulmonary injuries
por: Li, Ni, et al.
Publicado: (2021)

Plasma brain natriuretic peptide concentrations in patients with valvular heart disease
por: Sharma, Vishal, et al.
Publicado: (2016)

Significance of Atrial and Brain Natriuretic Peptide Measurements in Fetuses With Heart Failure
por: Miyoshi, Takekazu, et al.
Publicado: (2021)

The Use of Brain Natriuretic Peptide in the Evaluation of Heart Failure in Geriatric Patients
por: Marinescu, Mihai, et al.
Publicado: (2023)

Brain natriuretic peptide in acute brain diseases
por: Špatenková, V, et al.
Publicado: (2003)

B-type Natriuretic Peptide as an Index of Symptoms and Severity of Chronic Rheumatic Mitral Regurgitation
por: Abdel Fattah, Eman M., et al.
Publicado: (2016)

Brain Natriuretic Peptide and Its Biochemical, Analytical, and Clinical Issues in Heart Failure: A Narrative Review
por: Fu, Shihui, et al.
Publicado: (2018)

Brain Natriuretic Peptide Biomarkers in Current Clinical and Therapeutic Scenarios of Heart Failure
por: Alcidi, Gianmarco, et al.
Publicado: (2022)

In-hospital brain natriuretic peptide and N-terminal prohormone brain natriuretic peptide variations are predictors of short-term and long-term outcome in acute decompensated heart failure
por: Di Somma, Salvatore, et al.
Publicado: (2011)

Prognostic value of brain natriuretic peptide in patients with heart failure and reserved left ventricular systolic function
por: GONG, HUI, et al.
Publicado: (2014)

Correlation between B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide in patients presenting to an emergency department with decompensated heart failure
por: Villacorta, H, et al.
Publicado: (2005)

Protective effects of recombinant human brain natriuretic peptide in perioperative period during open heart surgery
por: Xu, Yunbin, et al.
Publicado: (2018)

Brain Natriuretic Peptide Production and Secretion in Inflammation
por: Ogawa, Tsuneo, et al.
Publicado: (2012)

Brain natriuretic peptide among stroke patients
por: Saritas, Ayhan, et al.
Publicado: (2014)

The diagnostic value of has_circ_0006423 in non-small cell lung cancer and its role as a tumor suppressor gene that sponges miR-492
por: Zhu, Linwen, et al.
Publicado: (2022)

Pharmacological Therapy in the Heart as an Alternative to Cellular Therapy: A Place for the Brain Natriuretic Peptide?
por: Rosenblatt-Velin, Nathalie, et al.
Publicado: (2016)

The predictive value of brain natriuretic peptide or N-terminal pro-brain natriuretic peptide for weaning outcome in mechanical ventilation patients: Evidence from SROC
por: Liu, Jian, et al.
Publicado: (2021)

C-type natriuretic peptide: the heart’s guardian angel
por: Sangaralingham, S Jeson, et al.
Publicado: (2020)

Role of Cardiac Natriuretic Peptides in Heart Structure and Function
por: Sarzani, Riccardo, et al.
Publicado: (2022)

Superiority of proatrial natriuretic peptide in the prognostic power in patients with acute decompensated heart failure on hospital admission: comparison with B-type natriuretic peptide and other natriuretic peptide forms
por: Takashio, Seiji, et al.
Publicado: (2019)

Interpretation and Use of Natriuretic Peptides in Non-Congestive Heart Failure Settings
por: Tsai, Shih-Hung, et al.
Publicado: (2010)

Ratio of preoperative atrial natriuretic peptide to brain natriuretic peptide predicts the outcome of the maze procedure in mitral valve disease
por: Sato, Masafumi, et al.
Publicado: (2013)

Artificial Intelligence-Enabled Electrocardiography Detects B-Type Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide
por: Liu, Pang-Yen, et al.
Publicado: (2023)

Relationship between serum brain natriuretic peptide and heart function in patients with chronic kidney disease
por: Yang, Jae Won, et al.
Publicado: (2008)

Serial Measurements of N-Terminal Pro-Brain Natriuretic Peptide in Patients with Coronary Heart Disease
por: Dallmeier, Dhayana, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j5m4pgpbs33la0fj1tvgfo94l5